Delayed administration of dexrazoxane provides cardioprotection against anthracyclines in breast cancer or acute myeloid leukemia
- PMID: 9336370
- DOI: 10.1200/JCO.1997.15.10.3293
Delayed administration of dexrazoxane provides cardioprotection against anthracyclines in breast cancer or acute myeloid leukemia
Comment on
-
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.J Clin Oncol. 1997 Apr;15(4):1333-40. doi: 10.1200/JCO.1997.15.4.1333. J Clin Oncol. 1997. PMID: 9193324 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
